ATPAF2 Gene Mitochondrial Complex V ATP Synthase Deficiency Nuclear Type 1 Genetic Test
Components
- Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Neurological Disorders
Doctor
Neurologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for ATPAF2 Gene Mitochondrial Complex V (ATP Synthase) Deficiency, Nuclear Type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ATPAF2 Gene Mitochondrial Complex V (ATP Synthase) Deficiency, Nuclear Type 1.
Test Details
ATPAF2 gene mitochondrial complex V (ATP synthase) deficiency, nuclear type 1 is a genetic disorder characterized by a mutation in the ATPAF2 gene. This gene is responsible for encoding a protein involved in the assembly and function of mitochondrial complex V, also known as ATP synthase. ATP synthase is an enzyme complex located in the inner mitochondrial membrane that plays a crucial role in the production of adenosine triphosphate (ATP), the primary energy source for cellular processes. Mutations in the ATPAF2 gene can disrupt the normal functioning of ATP synthase, leading to impaired ATP production.
NGS (Next-Generation Sequencing) Genetic Testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations associated with a particular condition. In the case of ATPAF2 gene mitochondrial complex V deficiency, NGS genetic testing can help identify the specific mutation in the ATPAF2 gene responsible for the disorder.
The genetic test involves obtaining a DNA sample from the patient, usually through a blood sample or cheek swab. The DNA is then sequenced using next-generation sequencing technology to identify any variations or mutations in the ATPAF2 gene. The results of the test can provide a definitive diagnosis of ATPAF2 gene mitochondrial complex V deficiency and can help guide treatment and management options for affected individuals.
It is important to note that genetic testing should be conducted and interpreted by healthcare professionals with expertise in genetics, as the results can have significant implications for individuals and their families. Genetic counseling is often recommended to help individuals understand the results and make informed decisions about their healthcare.
Test Name | ATPAF2 Gene Mitochondrial complex V ATP synthase deficiency nuclear type 1 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ATPAF2 Gene Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ATPAF2 Gene Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1 |
Test Details |
ATPAF2 gene mitochondrial complex V (ATP synthase) deficiency, nuclear type 1 is a genetic disorder characterized by a mutation in the ATPAF2 gene, which is responsible for encoding a protein involved in the assembly and function of mitochondrial complex V, also known as ATP synthase. ATP synthase is an enzyme complex located in the inner mitochondrial membrane that plays a crucial role in the production of adenosine triphosphate (ATP), the primary energy source for cellular processes. Mutations in the ATPAF2 gene can disrupt the normal functioning of ATP synthase, leading to impaired ATP production. NGS (Next-Generation Sequencing) Genetic Testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations associated with a particular condition. In the case of ATPAF2 gene mitochondrial complex V deficiency, NGS genetic testing can help identify the specific mutation in the ATPAF2 gene responsible for the disorder. The genetic test involves obtaining a DNA sample from the patient, usually through a blood sample or cheek swab. The DNA is then sequenced using next-generation sequencing technology to identify any variations or mutations in the ATPAF2 gene. The results of the test can provide a definitive diagnosis of ATPAF2 gene mitochondrial complex V deficiency and can help guide treatment and management options for affected individuals. It is important to note that genetic testing should be conducted and interpreted by healthcare professionals with expertise in genetics, as the results can have significant implications for individuals and their families. Genetic counseling is often recommended to help individuals understand the results and make informed decisions about their healthcare. |